Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
CALL
Revvity
RVTY
$12.8B
| $12.4M | 0.01% |
87,100
-29,900
| -26% | -$4.48M |
|
|
SGEN
1752
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.4M | 0.01% |
70,000
-55,000
| -44% | -$7.93M |
|
1753
Bruker
BRKR
$8.14B
| $12.4M | 0.01% |
197,337
-302,497
| -61% | -$18.5M |
|
1754
Skywest
SKYW
$4.34B
| $12.4M | 0.01% |
582,516
+207,329
| +55% | +$5.44M |
|
|
CWEN.A
1755
DELISTED
Clearway Energy Class A
CWEN.A
| $12.4M | 0.01% |
386,753
+26,414
| +7% | +$823K |
|
1756
PUT
Kimberly-Clark
KMB
$36.5B
| $12.4M | 0.01% |
91,400
-190,900
| -68% | -$25.1M |
|
|
TSPQ
1757
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $12.3M | 0.01% |
1,266,271
+192,875
| +18% | +$1.88M |
|
|
CD
1758
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $12.3M | 0.01% |
1,590,768
+1,513,030
| +1,946% | +$9.75M |
|
1759
Vaxcyte
PCVX
$8.64B
| $12.3M | 0.01% |
566,116
+303,396
| +115% | +$7.02M |
|
1760
PUT
Otis Worldwide
OTIS
$28.2B
| $12.3M | 0.01% |
174,300
+133,200
| +324% | +$9.81M |
|
1761
Oaktree Specialty Lending
OCSL
$1.14B
| $12.3M | 0.01% |
626,799
-463,477
| -43% | -$9.76M |
|
1762
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
| $12.3M | 0.01% |
228,305
+148,995
| +188% | +$8.76M |
|
1763
Hancock Whitney
HWC
$6.24B
| $12.3M | 0.01% |
277,523
+156,511
| +129% | +$7.45M |
|
|
1764
CALL
Boston Scientific
BSX
$71.5B
| $12.3M | 0.01% |
330,000
-500,000
| -60% | -$20.4M |
|
|
ROSS
1765
DELISTED
Ross Acquisition Corp II
ROSS
| $12.3M | 0.01% |
1,250,441
-1,964
| -0.2% | -$19.3K |
|
1766
Rambus
RMBS
$11B
| $12.3M | 0.01% |
571,003
+5,646
| +1% | +$140K |
|
|
GBT
1767
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.3M | 0.01% |
383,959
+71,916
| +23% | +$2.11M |
|
1768
Rush Enterprises Class A
RUSHA
$6.22B
| $12.3M | 0.01% |
381,606
+262,816
| +221% | +$8.78M |
|
1769
Axcelis
ACLS
$4.33B
| $12.2M | 0.01% |
223,150
-231,211
| -51% | -$13.4M |
|
1770
e.l.f. Beauty
ELF
$5.81B
| $12.2M | 0.01% |
398,702
-428,195
| -52% | -$10.8M |
|
|
CVSA
1771
Covista Inc
CVSA
$4.8B
| $12.2M | 0.01% |
+339,992
| New | +$10.7M |
|
1772
CALL
Vertex Pharmaceuticals
VRTX
$126B
| $12.2M | 0.01% |
+43,400
| New | +$11.6M |
|
|
AKIC
1773
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
| $12.2M | 0.01% |
1,242,684
-8,510
| -0.7% | -$84K |
|
1774
Carriage Services
CSV
$569M
| $12.2M | 0.01% |
307,860
+117,436
| +62% | +$5.07M |
|
1775
Envoy Medical
COCH
$51.7M
| $12.2M | 0.01% |
1,244,990
-19,103
| -2% | -$187K |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.